TEAS RF New Application

ELZONRIS

Stemline Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 87843152
Filing Date: 03/21/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87843152
MARK INFORMATION
*MARK ELZONRIS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ELZONRIS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Stemline Therapeutics, Inc.
*STREET 750 Lexington Avenue, 11th Floor
*CITY New York
*STATE
(Required for U.S. applicants)
New York
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
10022
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION pharmaceutical and biotechnological preparations, drugs, and diagnostic reagents for the diagnosis and treatment of cancer, auto-immune diseases and other diseases
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Jessica S. Parise
ATTORNEY DOCKET NUMBER STT-607
FIRM NAME Goodwin Procter LLP
INTERNAL ADDRESS The New York Times Building
STREET 620 Eighth Avenue
CITY New York
STATE New York
COUNTRY United States
ZIP/POSTAL CODE 10018
PHONE 212-813-8800
FAX 212-355-3333
EMAIL ADDRESS TMadmin@goodwinlaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Jennifer A. Albert; Steven R. Argentieri; Stephen G. Charkoudian; William D. Collins; Adam A. Chud; Robert M. Crawford, Jr.; James P. Devendorf; Kevin V. Lam; Ira J. Levy; Jeffrey R. Rummler; Jessica L. Rothstein; Gessingga N. Storer
CORRESPONDENCE INFORMATION
NAME Jessica S. Parise
FIRM NAME Goodwin Procter LLP
INTERNAL ADDRESS The New York Times Building
STREET 620 Eighth Avenue
CITY New York
STATE New York
COUNTRY United States
ZIP/POSTAL CODE 10018
PHONE 212-813-8800
FAX 212-355-3333
*EMAIL ADDRESS TMadmin@goodwinlaw.com; JParise@goodwinlaw.com; SAlliRampersad@goodwinlaw.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Robert Francomano/
SIGNATORY'S NAME Robert Francomano
SIGNATORY'S POSITION Vice President, Global Head of Commercial
SIGNATORY'S PHONE NUMBER 646-502-1946
DATE SIGNED 03/20/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 87843152
Filing Date: 03/21/2018

To the Commissioner for Trademarks:

MARK: ELZONRIS (Standard Characters, see mark)
The literal element of the mark consists of ELZONRIS.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Stemline Therapeutics, Inc., a corporation of Delaware, having an address of
      750 Lexington Avenue, 11th Floor
      New York, New York 10022
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  pharmaceutical and biotechnological preparations, drugs, and diagnostic reagents for the diagnosis and treatment of cancer, auto-immune diseases and other diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Jessica S. Parise and Jennifer A. Albert; Steven R. Argentieri; Stephen G. Charkoudian; William D. Collins; Adam A. Chud; Robert M. Crawford, Jr.; James P. Devendorf; Kevin V. Lam; Ira J. Levy; Jeffrey R. Rummler; Jessica L. Rothstein; Gessingga N. Storer of Goodwin Procter LLP
      The New York Times Building
      620 Eighth Avenue
      New York, New York 10018
      United States
      212-813-8800(phone)
      212-355-3333(fax)
      TMadmin@goodwinlaw.com (authorized)
The attorney docket/reference number is STT-607.
The applicant's current Correspondence Information:
      Jessica S. Parise
      Goodwin Procter LLP
      The New York Times Building
      620 Eighth Avenue
      New York, New York 10018
      212-813-8800(phone)
      212-355-3333(fax)
      TMadmin@goodwinlaw.com;JParise@goodwinlaw.com; SAlliRampersad@goodwinlaw.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Robert Francomano/   Date: 03/20/2018
Signatory's Name: Robert Francomano
Signatory's Position: Vice President, Global Head of Commercial
Payment Sale Number: 87843152
Payment Accounting Date: 03/21/2018

Serial Number: 87843152
Internet Transmission Date: Wed Mar 21 11:46:14 EDT 2018
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.X-2018032111461459
4445-87843152-510a9409ec0debbd6838958967
32eb143f3945ac6854fbd28e9a2283b6348a7272
-CC-9713-20180319152307861601

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed